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TuberculosisTuberculosis (TB) caused byMycobacterium tuberculosis remains a serious public health chal-
lenge towardswhich new hits are urgently needed. Medicinal plants remains amajor source
of new ligands against global infectious illnesses. In our laboratories, we are currently inves-
tigating locally used ethnobotanicals for novel compounds against zoonotic tuberculosis.
The microplate alamar blue assay (MABA) was used to study the anti-TB activity while the
CellTiter 96 AQueous Assay, which is composed of solutions of a novel tetrazolium
compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt; MTS] and an electron coupling reagent (phenazine methosulfate)
PMS, was used for cytotoxic studies. Correlation coefficients (R2) were used to compare the
relationship between antimycobacterial activity of the eight crude extracts against non-
pathogenic strains and the pathogenicMycobacterium bovis. Minimum inhibitory concentra-
tion (MICs) values indicated that all the eight tested medicinal plant species had activity
against all the three tested mycobacterial strains. Minimum inhibitory concentration value
as low as 19.5 mg/mL was observed against non-pathogenic strains M. bovis. Activity of the
crude extracts against M. aurum was the best predictor of natural product activity against
the pathogenic Mycobacterium bovis strain, with a correlation coefficient value (R2) of
0.1371. Results obtained from the current study validate, in part, the traditional utilization
of the tested medicinal plants against tuberculosis. The unripe fruits from Solanum torvum
are a potential source of safe and efficacious anti-TB crude drugs as well as a source for nat-
ural compounds that act asnewanti-infection agents, and thus deserve further investigation
towards development of a new class of molecules with activity against sensitive and drug
resistant strains of M. bovis.
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Tuberculosis (TB) caused by the Mycobacterium tuberculosis
complex represents a never-ending challenge towards which
drug discovery efforts are needed [1–3]. Several medicinal
plants are used traditionally in Ghanaian ethnomedicine to
treat TB [4]. In our ongoing research efforts aimed at drug dis-
covery against TB, we designed the current study to evaluate
the in vitro antimycobacterial activity and toxicity of eight
medicinal plants against pathogenic and nonpathogenic
mycobacterial strains. The study was further extended to
investigate the nonpathogenic mycobacterial strain which
best predicts natural product activity against the pathogenic
Mycobacterium bovis.
Material and methods
The microplate alamar blue assay was used to study the
anti-TB activity while the CellTiter 96 AQueous Assay, which
is composed of solutions of a novel tetrazolium compound
(3-[4,5-dimethylthiazol-2-yl]-5-[3-carboxymethoxyphenyl]-2-
[4-sulfophenyl]-2H-tetrazolium, inner salt; MTS) and an
electron coupling reagent (phenazine methosulfate) (Promega
Corporation, 2800 Woods Hollow RoadMadison, WI 53711
USA) was used for cytotoxic studies. Correlation coefficients
(R2) were used to compare the relationship between antimy-
cobacterial activity of the eight crude extracts against non-
pathogenic strains and the pathogenic M. bovis.
Results
Minimum inhibitory concentration values indicated that all
the eight tested medicinal plant species had activity against
all the three tested mycobacterial strains. Minimum inhibi-
tory concentration values of 19.5 lg/mL, 156.3 lg/mL, and
312.5 lg/mL were observed against nonpathogenic strains M.
bovis Bacillus Calmette–Gue´rin (American Type Culture Collec-
tion [ATCC] 3574) Mycobacterium aurum (ATCC 23366), and
the pathogenic strain M. bovis (ATCC 35720), respectively,
from the unripe fruits of Solanum torvum Sw. (Solanaceae).Please cite this article in press as: JM Nguta et al. In vitro antimycobacteria
nonpathogenic mycobacterial strains. Int. J. Mycobacteriol. (2016), http:/Cytotoxicity of the crude extracts towards human fetal lung
fibroblast cell lines (ATCC CCL-171) varied, and the unripe
fruits from S. torvum exhibited the most promising selectivity
index. Activity of the crude extracts againstM. aurum was the
best predictor of natural product activity against the patho-
genic M. bovis strain, with a correlation coefficient value (R2)
of 0.1371.
Conclusion
The results obtained from the current study validates, in part,
the traditional utilization of the tested medicinal plants
against TB. S. torvum unripe fruits have selective efficacy
against the studied mycobacteria, including M. bovis. The
unripe fruits from S. torvum are a potential source of safe
and efficacious anti-TB crude drugs as well as a source for
natural compounds that act as new anti-infection agents,
and thus deserve further investigation towards the develop-
ment of a new class of molecules with activity against sensi-
tive and drug-resistant strains of M. bovis.
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